{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:40:09Z","timestamp":1761896409871},"reference-count":66,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although all the peripheral T-cell lymphomas are uncommon, there are some entities that are truly rare. Subtypes, such as enteropathy-associated T-cell lymphoma, hepatosplenic T-cell lymphoma, extranodal NK\/T-cell lymphoma, and subcutaneous panniculitis-like T-cell lymphoma, have an approximate annual incidence in United States of &lt;500 each. In these very rare subtypes, there is limited data to guide clinical decision-making. As such, our treatment decisions are often based on extrapolation, case series, personal experience, and biases. We summarize the existing data regarding initial management of these entities and compare how that management follows paradigms established for the more common T-cell lymphomas.<\/jats:p>","DOI":"10.1182\/asheducation-2015.1.545","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T15:23:25Z","timestamp":1473953005000},"page":"545-549","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Zebras and hen's teeth: recognition and management of rare T and NK lymphomas"],"prefix":"10.1182","volume":"2015","author":[{"given":"Neha","family":"Mehta\u2013Shah","sequence":"first","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; and"},{"name":"Department of Medicine, Weill-Cornell Medical College, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"1","key":"2019111707515938300_B1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111707515938300_B2","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","article-title":"How I treat enteropathy-associated T-cell lymphoma","volume":"119","author":"Di Sabatino","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2019111707515938300_B3","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2012.219","article-title":"The prevalence of celiac disease in the United States","volume":"107","author":"Rubio-Tapia","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2019111707515938300_B4","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"2019111707515938300_B5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111707515938300_B6","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"issue":"18","key":"2019111707515938300_B7","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood"},{"issue":"13","key":"2019111707515938300_B8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2012-11-466839","article-title":"Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT","volume":"121","author":"Jantunen","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2019111707515938300_B9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.23213","article-title":"Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group","volume":"87","author":"Tse","year":"2012","journal-title":"Am J Hematol"},{"issue":"22","key":"2019111707515938300_B10","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","article-title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"122","author":"Perry","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2019111707515938300_B11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.hoc.2008.07.010","article-title":"Peripheral T-cell non-Hodgkin's lymphoma","volume":"22","author":"Vose","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"2019111707515938300_B12","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008"},{"issue":"11","key":"2019111707515938300_B13","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"issue":"2","key":"2019111707515938300_B14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1172\/JCI115044","article-title":"Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas","volume":"87","author":"Kanavaros","year":"1991","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111707515938300_B15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"Br J Cancer"},{"issue":"6","key":"2019111707515938300_B16","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/MIB.0b013e3182807618","article-title":"Do inflammatory bowel disease therapies cause cancer?","volume":"19","author":"Mason","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"13","key":"2019111707515938300_B17","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2019111707515938300_B18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"2019111707515938300_B19","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"issue":"3","key":"2019111707515938300_B20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"2019111707515938300_B21","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clml.2013.12.017","article-title":"Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?","volume":"14","author":"Ok","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"2019111707515938300_B22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/RLU.0b013e3181e4dcbf","article-title":"Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas","volume":"35","author":"Chan","year":"2010","journal-title":"Clin Nucl Med"},{"issue":"17","key":"2019111707515938300_B23","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"issue":"18","key":"2019111707515938300_B24","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"issue":"25","key":"2019111707515938300_B25","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","article-title":"How I treat NK\/T-cell lymphomas","volume":"121","author":"Tse","year":"2013","journal-title":"Blood"},{"issue":"12","key":"2019111707515938300_B26","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/sj.leu.2403955","article-title":"Natural killer-cell malignancies: diagnosis and treatment","volume":"19","author":"Kwong","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"2019111707515938300_B27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111707515938300_B28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111707515938300_B29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1011144911781","article-title":"CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma?","volume":"12","author":"Kim","year":"2001","journal-title":"Ann Oncol"},{"issue":"5","key":"2019111707515938300_B30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3109\/10428194.2013.827789","article-title":"The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer\/T-cell lymphoma, nasal type: a systematic review and meta-analysis","volume":"55","author":"Jiang","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2019111707515938300_B31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12185-010-0720-8","article-title":"Treatment of localized extranodal NK\/T cell lymphoma, nasal type","volume":"92","author":"Kim","year":"2010","journal-title":"Int J Hematol"},{"issue":"23","key":"2019111707515938300_B32","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","article-title":"Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"issue":"32","key":"2019111707515938300_B33","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2012.45.6541","article-title":"Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211","volume":"30","author":"Yamaguchi","year":"2012","journal-title":"J Clin Oncol"},{"issue":"33","key":"2019111707515938300_B34","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol"},{"issue":"35","key":"2019111707515938300_B35","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111707515938300_B36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02983387","article-title":"L-asparaginase-based regimen in the treatment of refractory midline nasal\/nasal-type T\/NK-cell lymphoma","volume":"78","author":"Yong","year":"2003","journal-title":"Int J Hematol"},{"issue":"2","key":"2019111707515938300_B37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cncr.27752","article-title":"First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"issue":"13","key":"2019111707515938300_B38","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/cncr.26629","article-title":"Phase 2 trial of \u201csandwich\u201d L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer\/T-cell lymphoma","volume":"118","author":"Jiang","year":"2012","journal-title":"Cancer"},{"issue":"15","key":"2019111707515938300_B39","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"issue":"33","key":"2019111707515938300_B40","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111707515938300_B41","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"key":"2019111707515938300_B42","first-page":"1","article-title":"High-dose therapy and autologous stem cell transplantation for extra-nodal NK\/T lymphoma in Western patients; a study from the European Society for Blood and Marrow Transplantation","author":"Fox","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2019111707515938300_B43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2009.239","article-title":"High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies","volume":"44","author":"Kwong","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2019111707515938300_B44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/bmt.2014.65","article-title":"Allogeneic haematopoietic SCT for natural killer\/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group","volume":"49","author":"Tse","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111707515938300_B45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.det.2008.05.008","article-title":"Subcutaneous panniculitic-like T-cell lymphoma and other primary cutaneous lymphomas with prominent subcutaneous tissue involvement","volume":"26","author":"Gallardo","year":"2008","journal-title":"Dermatol Clin"},{"issue":"2","key":"2019111707515938300_B46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.humpath.2003.09.015","article-title":"Clinicopathologic differences between 22 cases of CD56-negative and CD56-positive subcutaneous panniculitis-like lymphoma in Japan","volume":"35","author":"Takeshita","year":"2004","journal-title":"Hum Pathol"},{"issue":"11","key":"2019111707515938300_B47","first-page":"1372","article-title":"Cutaneous T-cell lymphomas (including rare subtypes): current concepts. II","volume":"89","author":"Paulli","year":"2004","journal-title":"Haematologica"},{"key":"2019111707515938300_B48","doi-asserted-by":"crossref","first-page":"vi149","DOI":"10.1093\/annonc\/mdt242","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Willemze","year":"2013","journal-title":"Ann Oncol"},{"issue":"6","key":"2019111707515938300_B49","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cncr.20502","article-title":"Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature","volume":"101","author":"Go","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"2019111707515938300_B50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00000421-199412000-00003","article-title":"Successful treatment of cytophagic histiocytic panniculitis with modified CHOP-E. Cyclophosphamide, adriamycin, vincristine, predonisone, and etoposide","volume":"17","author":"Matsue","year":"1994","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"2019111707515938300_B51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1705527","article-title":"Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation","volume":"38","author":"Perez-Persona","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2019111707515938300_B52","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1080\/10428190600783619","article-title":"Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor","volume":"47","author":"Ichii","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2019111707515938300_B53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.12659\/AOT.882007","article-title":"Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine","volume":"16","author":"Yuan","year":"2011","journal-title":"Ann Transplant"},{"issue":"6","key":"2019111707515938300_B54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1034\/j.1600-0609.2003.00058.x","article-title":"Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiation","volume":"70","author":"Mukai","year":"2003","journal-title":"Eur J Haematol"},{"issue":"1","key":"2019111707515938300_B55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clml.2011.06.016","article-title":"Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations","volume":"12","author":"Mehta","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"2019111707515938300_B56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4362.1996.tb01606.x","article-title":"Subcutaneous panniculitic T-cell lymphoma","volume":"35","author":"Wang","year":"1996","journal-title":"Int J Dermatol"},{"issue":"3","key":"2019111707515938300_B57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3816\/CLM.2002.n.024","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations","volume":"3","author":"Papenfuss","year":"2002","journal-title":"Clin Lymphoma"},{"issue":"3","key":"2019111707515938300_B58","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.annder.2008.07.061","article-title":"Two cases of subcutaneous panniculitis-like T-cell lymphoma (CD4\u2212 CD8+ CD56\u2212)[in French]","volume":"136","author":"Springinsfeld","year":"2009","journal-title":"Annales de dermatologie et de venereologie"},{"issue":"4","key":"2019111707515938300_B59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4143\/crt.2011.43.4.255","article-title":"Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-cell lymphoma after autologous hematopoietic stem cell transplantation","volume":"43","author":"Jung","year":"2011","journal-title":"Cancer Res Treat"},{"issue":"3","key":"2019111707515938300_B60","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4143\/crt.2014.46.3.312","article-title":"Cyclosporine A as a Primary Treatment for Panniculitis-like T Cell Lymphoma: a Case with a Long-Term Remission","volume":"46","author":"Lee","year":"2014","journal-title":"Cancer Res Treat"},{"issue":"8","key":"2019111707515938300_B61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3816\/CLM.2007.n.040","article-title":"Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma","volume":"7","author":"Hathaway","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"issue":"11","key":"2019111707515938300_B62","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2019111707515938300_B63","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"7","key":"2019111707515938300_B64","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/cas.12439","article-title":"Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the gammadelta phenotype from Japan","volume":"105","author":"Takahashi","year":"2014","journal-title":"Cancer Sci"},{"issue":"8","key":"2019111707515938300_B65","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","article-title":"Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation","volume":"35","author":"Garcia-Herrera","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2019111707515938300_B66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1309\/AJCPQGVLTZQ77VFF","article-title":"Indolent primary cutaneous gamma\/delta T-cell lymphoma localized to the subcutaneous panniculus and its association with atypical lymphocytic lobular panniculitis","volume":"138","author":"Magro","year":"2012","journal-title":"Am J Clin Pathol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/545\/1251092\/bep00115000545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/545\/1251092\/bep00115000545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T12:52:26Z","timestamp":1573995146000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2015\/1\/545\/20717\/Zebras-and-hens-teeth-recognition-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,5]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2015.1.545","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,5]]}}}